Donastas Sakellariou-Thompson

Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome

Marie‐Andrée Forget, Cara Haymaker, Kenneth R. Hess et al. · Clinical Cancer Research · 2018 · 135 citations · Full text

Medicine, Immunology, Oncology +17

Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

Aislyn Schalck, Donastas Sakellariou-Thompson, Marie‐Andrée Forget et al. · Cancer Discovery · 2022 · 79 citations · Full text

Life Sciences, Immunology, Oncology +17

4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer

Donastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy et al. · Clinical Cancer Research · 2017 · 61 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

Rodabe N. Amaria, Anne Knisely, David Vining et al. · Journal for ImmunoTherapy of Cancer · 2024 · 52 citations · Full text

Medicine, Immunology, Oncology +17

Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma

René J. Tavera, Marie‐Andrée Forget, Young Uk Kim et al. · Journal of Immunotherapy · 2018 · 48 citations

Life Sciences, Immunology, Oncology +17